In this short report, written on behalf of the Australian Society of Infectious Diseases (ASID) and endorsed by its council, we highlight recent changes to stool pathogen testing (particularly for parasites) within Australasian laboratories and alert clinicians to our concerns regarding result interpretation.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Stark D, Roberts T, Ellis JT, et al. Evaluation of the EasyScreen enteric parasite detection kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples. Diagn Microbiol Infect Dis 2014; 78: 149-152.
- 2. Roser D, Simonsen J, Nielsen HV, et al. Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR. Eur J Clin Microbiol Infect Dis 2013; 32: 1303-1310.
- 3. Byrne S, Robson JM. Advances in molecular diagnosis of parasitic enteropathogens. Pathology 2015; 47: 234-242.
- 4. Roser D, Simonsen J, Stensvold CR, et al. Metronidazole therapy for treating dientamoebiasis in children is not associated with better clinical outcomes: a randomized, double-blinded and placebo-controlled clinical trial. Clin Infect Dis 2014; 58: 1692-1699.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.